 |
 |
|
|
RESÚMENES ABRIL 2006 |
Mood - Anxiety Disorders & Antidepressants – Mood
Stabilizers
(Haga un click en la
información del journal para acceder al resúmen)
MAOI Skin Patch Wins FDA Approval for Depression
Jim Rosack
Psychiatr News April 7, 2006. Volume 41, Number 7, page 31
Early Bipolar Disorder Markers Target of
Long-Term Study
Joan Arehart-Treichel
Psychiatr News April 7, 2006. Volume
41, Number 7, page 33
Racial and Ethnic Differences in the
Relationship Between Depression Severity and
Functional Status
Frederick Y.
Huang, Henry Chung, Kurt Kroenke, and Robert L. Spitzer
Psychiatr Serv
57:498-503, April 2006
Does the Clinical Course of Depression Determine
Improvement in Symptoms and Quality of Life?
Moses, Tally; Leuchter,
Andrew F.; Cook, Ian; Abrams, Michelle
Journal of Nervous & Mental
Disease. 194(4):241-248, April
2006
Extended-release carbamazepine
capsules as monotherapy in bipolar disorder
: pooled results from two randomised,
double-blind, placebo-controlled trials.
Weisler RH, Hirschfeld R, Cutler AJ, Gazda T,
Ketter TA, Keck PE, Swann A, Kalali
A; and the SPD417 Study Group
Continuation and Maintenance Electroconvulsive
Therapy for the Treatment of Depressive Illness: A Response to the National
Institute for Clinical Excellence Report
Frederikse, Melissa; Petrides, Georgios; Kellner, Charles
Journal of ECT. 22(1):13-17, March 2006
What Predicts Patients' Expressed Likelihood of
Choosing Electroconvulsive Therapy as a Future Treatment Option?
Rosenquist, Peter B.; Dunn, Aaron; Rapp, Stephen; Gaba, Aline;
McCall, W. Vaughn
Journal of ECT. 22(1):33-37, March 2006
What is the Optimal Duration of a Short-term
Antidepressant Trial When Treating Geriatric Depression?
Mulsant, Benoit H.; Houck, Patricia R.; Gildengers, Ariel G.; Andreescu,
Carmen; Dew, Mary Amanda; Pollock, Bruce G.; Miller, Mark D.; Stack, Jacqueline
A.; Mazumdar, Sati; Reynolds, Charles F. III
Journal of Clinical
Psychopharmacology. 26(2):113-120,
April 2006
Efficacy and Tolerability of Reboxetine
Compared with Citalopram: A Double-blind Study in
Patients with Major Depressive Disorder
Langworth, Sven; Bodlund, Owe; Agren, Hans
Journal of Clinical
Psychopharmacology. 26(2):121-127,
April 2006
Reboxetine
Versus Fluvoxamine in the Treatment of Motor Vehicle
Accident-related Posttraumatic Stress Disorder: A Double-blind, Fixed-dosage,
Controlled Trial
Spivak, Baruch; Strous, Rael D; Shaked, Ginette; Shabash, Evgeny; Kotler, Moshe; Weizman, Abraham
Journal of Clinical
Psychopharmacology. 26(2):152-156,
April 2006
Escitalopram, but
Not Its Major Metabolites, Exhibits Antiplatelet
Activity in Humans
Atar, Dan; Malinin, Alex; Takserman, Aviv; Pokov, Alex; van
Zyl, Louis; Tanguay,
Jean-Francois; Lesperance, Francois; Serebruany, Victor
Journal of Clinical Psychopharmacology. 26(2):172-177, April 2006
Cognitive Functioning in Bipolar Patients Receiving
Lamotrigine: Preliminary Results
Daban, Claire; Martinez-Aran, Anabel; Torrent, Carla; Sanchez-Moreno, Jose; Goikolea, Jose Manuel; Benabarre,
Antonio; Comes, Merce; Colom,
Francesc; Vieta, Eduard
Journal of Clinical
Psychopharmacology. 26(2):178-181,
April 2006
Risk Factors for Extrapyramidal
Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors,
Including Cytochrome P-450 Enzyme, and Serotonin and
Dopamine Transporter and Receptor Polymorphisms
Hedenmalm, Karin; Guzey, Cuneyt; Dahl, Marja-Liisa; Yue, Qun-Ying; Spigset, Olav
Journal of Clinical
Psychopharmacology. 26(2):192-197,
April 2006
Suicide Rates in Short-term Randomized Controlled
Trials of Newer Antidepressants
Hammad, Tarek A.; Laughren, Thomas P.; Racoosin,
Judith A
Journal of Clinical
Psychopharmacology. 26(2):203-207,
April 2006
A
comparative study of fluoxetine, moclobemide,
and tianeptine in the treatment of posttraumatic
stress disorder following an earthquake
E. Önder, Ü. Tural and T. Aker
European Psychiatry. Volume 21, Issue 3, April 2006, Pages 174-179
Changes of Sleep Architecture, Spectral
Composition of Sleep EEG, the Nocturnal Secretion of Cortisol,
ACTH, GH, Prolactin, Melatonin, Ghrelin,
and Leptin, and the DEX-CRH Test in Depressed
Patients during Treatment with Mirtazapine
Dagmar A Schmid, Adam Wichniak, Manfred Uhr, Marcus Ising, Hans Brunner, Katja Held, Jutta C Weikel, Annette Sonntag and Axel Steiger
Neuropsychopharmacology (2006) 31,
832-844
A Double-Blind, Placebo-Controlled Study of Venlafaxine and Fluoxetine in Geriatric Outpatients With Major Depression
Alan Schatzberg, and Steven Roose
Am J Geriatr Psychiatry
14:361-370, April 2006
Psychotherapy plus antidepressant for panic disorder with or without agoraphobia. Systematic review
TOSHI A. FURUKAWA, NORIO WATANABE, RACHEL CHURCHILL
The
British Journal of Psychiatry (2006) 188: 305-312
Cost-effectiveness and cost-utility of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Randomised controlled trial
TONY KENDRICK, ROBERT PEVELER, LOUISE LONGWORTH, DAVID
BALDWIN, MICHAEL MOORE, JUDY CHATWIN, ANDREW THORNETT, JONATHAN GODDARD,
MICHAEL CAMPBELL, HELEN SMITH, MARTIN BUXTON, CHRISTOPHER THOMPSON
The
British Journal of Psychiatry (2006) 188: 337-345
Duloxetine in the prevention of relapse of major depressive disorder. Double-blind placebo-controlled study
DAVID G. PERAHIA, INMACULADA GILABERTE, FUJUN WANG, CURTIS
G. WILTSE, STACY A. HUCKINS, JEFFREY W. CLEMENS, STUART A. MONTGOMERY, ANGEL L.
MONTEJO, MICHAEL J. DETKE
The
British Journal of Psychiatry (2006) 188: 346-353
Relationship between antidepressant sales and secular trends in suicide rates in the Nordic countries
SVEIN RESELAND, ISABELLE BRAY, and DAVID GUNNELL
The
British Journal of Psychiatry (2006) 188: 354-358
McMahon et al.
Science 31 March 2006: Vol. 311. no. 5769, p. 1843
Associations of Hormones and Menopausal Status With Depressed Mood in Women With No History of Depression
Ellen W. Freeman, Mary D. Sammel,
Hui Lin, Deborah B. Nelson
Arch Gen Psychiatry. 2006;63:375-382
Risk for New Onset of Depression During
the Menopausal Transition. The Harvard Study
of Moods and Cycles
Lee S. Cohen, Claudio N. Soares,
Allison F. Vitonis, Michael W. Otto, Bernard L.
Harlow
Arch Gen Psychiatry. 2006;63:385-390
The Epidemiology of Panic Attacks, Panic Disorder,
and Agoraphobia in the National Comorbidity Survey
Replication
Ronald C. Kessler, Wai
Tat Chiu, Robert Jin, Ayelet Meron
Ruscio, Katherine Shear, Ellen E. Walters
Arch Gen Psychiatry. 2006;63:415-424
Brain pH Response to Hyperventilation in Panic Disorder: Preliminary Evidence for Altered Acid-Base Regulation
Seth D. Friedman, C. Mark Mathis, Cecil Hayes, Perry Renshaw, and Stephen R. Dager
American Journal of Psychiatry 163:710-715, April 2006
Outcomes of Minor and Subsyndromal Depression among Elderly Patients in Primary Care Settings
Jeffrey M. Lyness, Moonseong Heo, Catherine J. Datto, Thomas R. Ten Have, Ira R. Katz, Rebecca Drayer, Charles F. Reynolds, III, George S. Alexopoulos, and Martha L. Bruce
Ann Intern Med. 4 April 2006 | Volume 144 Issue 7 |
Pages 496-504
Antidepressant
efficacy of olanzapine as monotherapy
in major depressive disorder, without psychosis: A pilot study
Jose
Mathews, Keith S. Garcia, Mark A. Mintun and Yvette
I. Sheline
Psychiatry Research: Neuroimaging.
Volume 146, Issue 2, 31 March 2006, Pages 149-155
Charles
R. Conway, Yvette I. Sheline, John T. Chibnall, Mark S. George, James W. Fletcher and Mark A. Mintun
Psychiatry Research: Neuroimaging.
Volume 146, Issue 2, 31 March 2006, Pages 179-184
L Douglas Ried, Michael J Tueth, Michael D Taylor, Brian C Sauer, Larry M Lopez, Carl
J Pepine
The Annals of Pharmacotherapy: Vol. 40, No. 4, pp.
597-604
Depression in Patients with Type 2 Diabetes: Impact on Adherence to Oral Hypoglycemic Agents
Iftekhar D Kalsekar, Suresh S Madhavan, Mayur M Amonkar, Eugene H Makela,
Virginia G Scott,
The Annals of Pharmacotherapy:
Vol. 40, No. 4, pp. 605-611
A double-blind, randomised,
controlled clinical trial of acetyl-l-carnitine vs. amisulpride in the
treatment of dysthymia
R. Zanardi and E. Smeraldi
European Neuropsychopharmacology. Volume 16, Issue 4, May 2006, Pages 281-287
Advances
in the Treatment of Depression
Paul E. Holtzheimer
III, Charles B. Nemeroff
NeuroRx. Volume 3, Issue 1, Pages 42-56 (January 2006)
Glutamate-Modulating
Drugs as Novel Pharmacotherapeutic Agents in the Treatment of
Obsessive-Compulsive Disorder
Christopher Pittenger,
John H. Krystal,
NeuroRx. Volume 3, Issue 1, Pages 69-81 (January 2006)
Use of Psychotropic
Medications in Treating Mood Disorders during Lactation: Practical
Recommendations
Eberhard-Gran, Malin; Eskild, Anne; Opjordsmoen, Stein
CNS Drugs. 20(3):187-198, 2006
Efficacy of etifoxine
compared to lorazepam monotherapy
in the treatment of patients with adjustment disorders with anxiety: a
double-blind controlled study in general practice
N. Nguyen, E. Fakra, V.
Pradel, E. Jouve, C. Alquier, M-E. Le Guern, J. Micallef, O. Blin
Human
Psychopharmacology: Clinical and Experimental. Volume 21, Issue 3, Pages 139 -
149
Human
Psychopharmacology: Clinical and Experimental. Volume 21, Issue 3, Pages 189 -
193
Does
work on obsessive–compulsive spectrum disorders contribute to understanding the
heterogeneity of obsessive–compulsive disorder?
Christine Lochner and Dan J. Stein
Mechanisms
of action of current and potential pharmacotherapies
of obsessive-compulsive disorder
Mostafa El Mansari
and Pierre Blier
Relapse
during a 6-month continuation treatment with fluvoxamine
in an Italian population: The role of clinical, psychosocial and genetic
variables
Danilo Dotoli, Chiara Spagnolo, Fanny Bongiorno, Raffaella Zanardi,
Alessandro Serretti, Enrico Smeraldi and Linda Franchini
Franco Benazzi
Plasma
levels of homovanillic acid, 5-hydroxyindoleacetic
acid and cortisol, and serotonin turnover in
depressed patients
Hideaki Mitani, Yukihiko Shirayama, Takeshi Yamada and Ryuzou
Kawahara
Lack of
Effects on Core Obsessive-Compulsive Symptoms of Tryptophan
Depletion During Symptom Provocation in Remitted
Obsessive-Compulsive Disorder Patients
Alexandre Berney,
Debbie Sookman, Marco Leyton,
Simon N. Young and Chawki Benkelfat
Biological Psychiatry. Volume 59, Issue 9, 1 May 2006, Pages 853-857
Do personality traits
predict first onset in depressive and bipolar disorder?
Maj Vinberg Christensen and Lars Vedel Kessing
Nordic Journal of Psychiatry. Volume 60, Number 02 / March 2006: 79 - 88
Olanzapine plasma level in relation to antimanic
effect in the acute therapy of manic states
P. Bech, M. Gex-Fabry, J.-M. Aubry, S. Favre, G. Bertschy
Nordic Journal of Psychiatry. Volume 60, Number 02 / March 2006:181 - 182
Current
Status of Augmentation and Combination Treatments for Major Depressive
Disorder: A Literature Review and a Proposal for a Novel Approach to Improve
Practice
Maurizio Fava, A. John Rush
Psychotherapy
and Psychosomatics 2006;75:139-153
Panic and suicidal ideation and suicide
attempts: results from the National Comorbidity
Survey
Renee D.
Goodwin, Peter Roy-Byrne
Depression
and Anxiety 23:124-132, 2006
Thomas
J. Raedler, Holger Jahn, Birgit Goedeken, Dorothee M. Gescher, Michael Kellner, Klaus Wiedemann
Depression
and Anxiety 23:139-144, 2006
Laurie
B. Slone, Fran H. Norris, Arthur D. Murphy, Charlene K. Baker, Julia L. Perilla, Dayna Diaz, Francisco Gutiérrez Rodriguez, José de Jesús
Gutiérrez Rodriguez
Depression
and Anxiety 23:158-167, 2006
The combination of duloxetine
and bupropion for treatment-resistant major
depressive disorder
George
I. Papakostas, John J. Worthington III, Dan V. Iosifescu, Gustavo Kinrys, Alana
M. Burns, Lauren B. Fisher, Caitlin H. Homberger,
David Mischoulon, Maurizio Fava
Depression
and Anxiety 0:1-4, 2006
Differences in Axis I and II Comorbidity Between Bipolar I and II Disorders and Major Depressive Disorder
Outi Mantere, Tarja K. Melartin, Kirsi Suominen, Heikki J. Rytsälä, Hanna
M. Valtonen, Petri Arvilommi, Sami Leppämäki, and Erkki T. Isometsä
J Clin Psychiatry 2006;67:584-593
Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Obsessive-Compulsive Disorder: A Critical Review
Bernardo
Dell'Osso, Gerald Nestadt,
Andrea Allen, and Eric Hollander
J Clin Psychiatry 2006;67:600-610
A Randomized, Double-Blind, Placebo-Controlled 26-Week Trial of Aripiprazole in Recently Manic Patients With Bipolar I Disorder
Paul E.
Keck, Jr., Joseph R. Calabrese, Robert D. McQuade,
William H. Carson, Berit X. Carlson, Linda M. Rollin,
Ronald N. Marcus, and Raymond Sanchez, for the Aripiprazole
Study Group
J Clin Psychiatry 2006;67:626-637
Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials
Roy
H. Perlis, Jeffrey A. Welge, Lana A. Vornik, Robert M. A. Hirschfeld,
and Paul E. Keck, Jr.
J Clin Psychiatry 2006;67:509-516
Makiko Goto, Reiji Yoshimura, Shingo Kakihara,
Koji Shinkai, Yasuhisa Yamada, Kyoko Kaji, Nobuhisa Ueda and Jun
Nakamura
A multiwave multi-informant study of the specificity of the
association between parental and offspring psychiatric disorders
Jeffrey
G. Johnson, Patricia Cohen, Stephanie Kasen and Judith
S. Brook
Comprehensive Psychiatry. Volume 47, Issue 3, May-June 2006, Pages 169-177
Psychopathological profile of 35% CO2
challenge test–induced panic attacks: a comparison with spontaneous panic
attacks
Antonio
E. Nardi, Alexandre M. Valença, Fabiana L. Lopes,
Isabella Nascimento, Andre B. Veras,
Rafael C. Freire, Marco A. Mezzasalma,
Valfrido L. de-Melo-Neto
and Walter A. Zin
Comprehensive Psychiatry. Volume 47, Issue 3, May-June 2006, Pages 209-214